nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Metabolic alkalosis—Furosemide—dilated cardiomyopathy	0.0666	0.0666	CcSEcCtD
Fondaparinux sodium—Nephrocalcinosis—Furosemide—dilated cardiomyopathy	0.0557	0.0557	CcSEcCtD
Fondaparinux sodium—Tetany—Furosemide—dilated cardiomyopathy	0.0296	0.0296	CcSEcCtD
Fondaparinux sodium—Gastric irritation—Furosemide—dilated cardiomyopathy	0.0249	0.0249	CcSEcCtD
Fondaparinux sodium—Bullous eruption—Furosemide—dilated cardiomyopathy	0.0244	0.0244	CcSEcCtD
Fondaparinux sodium—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.0203	0.0203	CcSEcCtD
Fondaparinux sodium—Ulcer—Spironolactone—dilated cardiomyopathy	0.0188	0.0188	CcSEcCtD
Fondaparinux sodium—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.0184	0.0184	CcSEcCtD
Fondaparinux sodium—Local reaction—Furosemide—dilated cardiomyopathy	0.0174	0.0174	CcSEcCtD
Fondaparinux sodium—Eruption—Furosemide—dilated cardiomyopathy	0.0157	0.0157	CcSEcCtD
Fondaparinux sodium—Leg pain—Lisinopril—dilated cardiomyopathy	0.0157	0.0157	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.014	0.014	CcSEcCtD
Fondaparinux sodium—Thrombosis—Furosemide—dilated cardiomyopathy	0.0136	0.0136	CcSEcCtD
Fondaparinux sodium—Blister—Furosemide—dilated cardiomyopathy	0.0134	0.0134	CcSEcCtD
Fondaparinux sodium—Fluid overload—Lisinopril—dilated cardiomyopathy	0.0117	0.0117	CcSEcCtD
Fondaparinux sodium—Gastritis—Spironolactone—dilated cardiomyopathy	0.0114	0.0114	CcSEcCtD
Fondaparinux sodium—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0106	0.0106	CcSEcCtD
Fondaparinux sodium—Drug interaction—Furosemide—dilated cardiomyopathy	0.0104	0.0104	CcSEcCtD
Fondaparinux sodium—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00979	0.00979	CcSEcCtD
Fondaparinux sodium—Renal failure—Spironolactone—dilated cardiomyopathy	0.00976	0.00976	CcSEcCtD
Fondaparinux sodium—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00864	0.00864	CcSEcCtD
Fondaparinux sodium—Swelling—Furosemide—dilated cardiomyopathy	0.00795	0.00795	CcSEcCtD
Fondaparinux sodium—Oliguria—Lisinopril—dilated cardiomyopathy	0.00787	0.00787	CcSEcCtD
Fondaparinux sodium—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00784	0.00784	CcSEcCtD
Fondaparinux sodium—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00781	0.00781	CcSEcCtD
Fondaparinux sodium—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00761	0.00761	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00734	0.00734	CcSEcCtD
Fondaparinux sodium—Purpura—Furosemide—dilated cardiomyopathy	0.00728	0.00728	CcSEcCtD
Fondaparinux sodium—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00725	0.00725	CcSEcCtD
Fondaparinux sodium—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00688	0.00688	CcSEcCtD
Fondaparinux sodium—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00684	0.00684	CcSEcCtD
Fondaparinux sodium—Irritability—Furosemide—dilated cardiomyopathy	0.00669	0.00669	CcSEcCtD
Fondaparinux sodium—Urinary retention—Furosemide—dilated cardiomyopathy	0.00667	0.00667	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00657	0.00657	CcSEcCtD
Fondaparinux sodium—Dehydration—Furosemide—dilated cardiomyopathy	0.00652	0.00652	CcSEcCtD
Fondaparinux sodium—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00649	0.00649	CcSEcCtD
Fondaparinux sodium—Confusional state—Spironolactone—dilated cardiomyopathy	0.00639	0.00639	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00638	0.00638	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00634	0.00634	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0062	0.0062	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0061	0.0061	CcSEcCtD
Fondaparinux sodium—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00602	0.00602	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.0057	0.0057	CcSEcCtD
Fondaparinux sodium—Somnolence—Spironolactone—dilated cardiomyopathy	0.00563	0.00563	CcSEcCtD
Fondaparinux sodium—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00555	0.00555	CcSEcCtD
Fondaparinux sodium—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00553	0.00553	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00547	0.00547	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00537	0.00537	CcSEcCtD
Fondaparinux sodium—Renal failure—Furosemide—dilated cardiomyopathy	0.00531	0.00531	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00526	0.00526	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00522	0.00522	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00511	0.00511	CcSEcCtD
Fondaparinux sodium—Urticaria—Spironolactone—dilated cardiomyopathy	0.00503	0.00503	CcSEcCtD
Fondaparinux sodium—Irritability—Lisinopril—dilated cardiomyopathy	0.00502	0.00502	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00501	0.00501	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.005	0.005	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00493	0.00493	CcSEcCtD
Fondaparinux sodium—Dehydration—Lisinopril—dilated cardiomyopathy	0.00489	0.00489	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00467	0.00467	CcSEcCtD
Fondaparinux sodium—Gastritis—Lisinopril—dilated cardiomyopathy	0.00466	0.00466	CcSEcCtD
Fondaparinux sodium—Pruritus—Spironolactone—dilated cardiomyopathy	0.00448	0.00448	CcSEcCtD
Fondaparinux sodium—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00447	0.00447	CcSEcCtD
Fondaparinux sodium—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00443	0.00443	CcSEcCtD
Fondaparinux sodium—Angiopathy—Furosemide—dilated cardiomyopathy	0.0044	0.0044	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00438	0.00438	CcSEcCtD
Fondaparinux sodium—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00437	0.00437	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00433	0.00433	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00433	0.00433	CcSEcCtD
Fondaparinux sodium—Malnutrition—Furosemide—dilated cardiomyopathy	0.00422	0.00422	CcSEcCtD
Fondaparinux sodium—Dizziness—Spironolactone—dilated cardiomyopathy	0.00419	0.00419	CcSEcCtD
Fondaparinux sodium—Flatulence—Furosemide—dilated cardiomyopathy	0.00416	0.00416	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00414	0.00414	CcSEcCtD
Fondaparinux sodium—Vomiting—Spironolactone—dilated cardiomyopathy	0.00403	0.00403	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.004	0.004	CcSEcCtD
Fondaparinux sodium—Rash—Spironolactone—dilated cardiomyopathy	0.00399	0.00399	CcSEcCtD
Fondaparinux sodium—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00399	0.00399	CcSEcCtD
Fondaparinux sodium—Renal failure—Lisinopril—dilated cardiomyopathy	0.00399	0.00399	CcSEcCtD
Fondaparinux sodium—Vision blurred—Furosemide—dilated cardiomyopathy	0.00398	0.00398	CcSEcCtD
Fondaparinux sodium—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00397	0.00397	CcSEcCtD
Fondaparinux sodium—Headache—Spironolactone—dilated cardiomyopathy	0.00397	0.00397	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00394	0.00394	CcSEcCtD
Fondaparinux sodium—Anaemia—Furosemide—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Fondaparinux sodium—Haematuria—Lisinopril—dilated cardiomyopathy	0.00387	0.00387	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00383	0.00383	CcSEcCtD
Fondaparinux sodium—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00382	0.00382	CcSEcCtD
Fondaparinux sodium—Vertigo—Furosemide—dilated cardiomyopathy	0.00379	0.00379	CcSEcCtD
Fondaparinux sodium—Nausea—Spironolactone—dilated cardiomyopathy	0.00376	0.00376	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00359	0.00359	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00357	0.00357	CcSEcCtD
Fondaparinux sodium—Confusional state—Furosemide—dilated cardiomyopathy	0.00348	0.00348	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00345	0.00345	CcSEcCtD
Fondaparinux sodium—Shock—Furosemide—dilated cardiomyopathy	0.00339	0.00339	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00338	0.00338	CcSEcCtD
Fondaparinux sodium—Flushing—Lisinopril—dilated cardiomyopathy	0.00338	0.00338	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00337	0.00337	CcSEcCtD
Fondaparinux sodium—Skin disorder—Furosemide—dilated cardiomyopathy	0.00335	0.00335	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00333	0.00333	CcSEcCtD
Fondaparinux sodium—Angiopathy—Lisinopril—dilated cardiomyopathy	0.0033	0.0033	CcSEcCtD
Fondaparinux sodium—Anorexia—Furosemide—dilated cardiomyopathy	0.00329	0.00329	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00328	0.00328	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00325	0.00325	CcSEcCtD
Fondaparinux sodium—Hypotension—Furosemide—dilated cardiomyopathy	0.00322	0.00322	CcSEcCtD
Fondaparinux sodium—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00317	0.00317	CcSEcCtD
Fondaparinux sodium—Flatulence—Lisinopril—dilated cardiomyopathy	0.00312	0.00312	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.0031	0.0031	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00309	0.00309	CcSEcCtD
Fondaparinux sodium—Back pain—Lisinopril—dilated cardiomyopathy	0.00306	0.00306	CcSEcCtD
Fondaparinux sodium—Somnolence—Furosemide—dilated cardiomyopathy	0.00306	0.00306	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Furosemide—dilated cardiomyopathy	0.003	0.003	CcSEcCtD
Fondaparinux sodium—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00299	0.00299	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00298	0.00298	CcSEcCtD
Fondaparinux sodium—Fatigue—Furosemide—dilated cardiomyopathy	0.00297	0.00297	CcSEcCtD
Fondaparinux sodium—Pain—Furosemide—dilated cardiomyopathy	0.00295	0.00295	CcSEcCtD
Fondaparinux sodium—Constipation—Furosemide—dilated cardiomyopathy	0.00295	0.00295	CcSEcCtD
Fondaparinux sodium—Anaemia—Lisinopril—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Fondaparinux sodium—Angioedema—Lisinopril—dilated cardiomyopathy	0.0029	0.0029	CcSEcCtD
Fondaparinux sodium—Vertigo—Lisinopril—dilated cardiomyopathy	0.00285	0.00285	CcSEcCtD
Fondaparinux sodium—Syncope—Lisinopril—dilated cardiomyopathy	0.00284	0.00284	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00284	0.00284	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00282	0.00282	CcSEcCtD
Fondaparinux sodium—Palpitations—Lisinopril—dilated cardiomyopathy	0.0028	0.0028	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00278	0.00278	CcSEcCtD
Fondaparinux sodium—Cough—Lisinopril—dilated cardiomyopathy	0.00277	0.00277	CcSEcCtD
Fondaparinux sodium—Urticaria—Furosemide—dilated cardiomyopathy	0.00274	0.00274	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00272	0.00272	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00272	0.00272	CcSEcCtD
Fondaparinux sodium—Chest pain—Lisinopril—dilated cardiomyopathy	0.0027	0.0027	CcSEcCtD
Fondaparinux sodium—Anxiety—Lisinopril—dilated cardiomyopathy	0.00269	0.00269	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00268	0.00268	CcSEcCtD
Fondaparinux sodium—Confusional state—Lisinopril—dilated cardiomyopathy	0.00261	0.00261	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00259	0.00259	CcSEcCtD
Fondaparinux sodium—Oedema—Lisinopril—dilated cardiomyopathy	0.00259	0.00259	CcSEcCtD
Fondaparinux sodium—Infection—Lisinopril—dilated cardiomyopathy	0.00257	0.00257	CcSEcCtD
Fondaparinux sodium—Shock—Lisinopril—dilated cardiomyopathy	0.00254	0.00254	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00254	0.00254	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00253	0.00253	CcSEcCtD
Fondaparinux sodium—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00252	0.00252	CcSEcCtD
Fondaparinux sodium—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00251	0.00251	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.0025	0.0025	CcSEcCtD
Fondaparinux sodium—Asthenia—Furosemide—dilated cardiomyopathy	0.00247	0.00247	CcSEcCtD
Fondaparinux sodium—Anorexia—Lisinopril—dilated cardiomyopathy	0.00247	0.00247	CcSEcCtD
Fondaparinux sodium—Pruritus—Furosemide—dilated cardiomyopathy	0.00244	0.00244	CcSEcCtD
Fondaparinux sodium—Hypotension—Lisinopril—dilated cardiomyopathy	0.00242	0.00242	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00236	0.00236	CcSEcCtD
Fondaparinux sodium—Insomnia—Lisinopril—dilated cardiomyopathy	0.00234	0.00234	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00232	0.00232	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00231	0.00231	CcSEcCtD
Fondaparinux sodium—Somnolence—Lisinopril—dilated cardiomyopathy	0.0023	0.0023	CcSEcCtD
Fondaparinux sodium—Dizziness—Furosemide—dilated cardiomyopathy	0.00228	0.00228	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00228	0.00228	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00225	0.00225	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00223	0.00223	CcSEcCtD
Fondaparinux sodium—Fatigue—Lisinopril—dilated cardiomyopathy	0.00223	0.00223	CcSEcCtD
Fondaparinux sodium—Constipation—Lisinopril—dilated cardiomyopathy	0.00221	0.00221	CcSEcCtD
Fondaparinux sodium—Pain—Lisinopril—dilated cardiomyopathy	0.00221	0.00221	CcSEcCtD
Fondaparinux sodium—Vomiting—Furosemide—dilated cardiomyopathy	0.00219	0.00219	CcSEcCtD
Fondaparinux sodium—Rash—Furosemide—dilated cardiomyopathy	0.00217	0.00217	CcSEcCtD
Fondaparinux sodium—Dermatitis—Furosemide—dilated cardiomyopathy	0.00217	0.00217	CcSEcCtD
Fondaparinux sodium—Headache—Furosemide—dilated cardiomyopathy	0.00216	0.00216	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00213	0.00213	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00211	0.00211	CcSEcCtD
Fondaparinux sodium—Urticaria—Lisinopril—dilated cardiomyopathy	0.00205	0.00205	CcSEcCtD
Fondaparinux sodium—Nausea—Furosemide—dilated cardiomyopathy	0.00205	0.00205	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00204	0.00204	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00204	0.00204	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00191	0.00191	CcSEcCtD
Fondaparinux sodium—Asthenia—Lisinopril—dilated cardiomyopathy	0.00186	0.00186	CcSEcCtD
Fondaparinux sodium—Pruritus—Lisinopril—dilated cardiomyopathy	0.00183	0.00183	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00177	0.00177	CcSEcCtD
Fondaparinux sodium—Dizziness—Lisinopril—dilated cardiomyopathy	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Vomiting—Lisinopril—dilated cardiomyopathy	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Rash—Lisinopril—dilated cardiomyopathy	0.00163	0.00163	CcSEcCtD
Fondaparinux sodium—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00163	0.00163	CcSEcCtD
Fondaparinux sodium—Headache—Lisinopril—dilated cardiomyopathy	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Nausea—Lisinopril—dilated cardiomyopathy	0.00154	0.00154	CcSEcCtD
